The aims of the present study were to: compare the characteristics between antisynthetase
syndrome (ASS) patients with anti-Jo1 antibody and those with anti-PL7/PL12 antibody. The …

Recent progress in the management of rheumatoid arthritis (RA) is turning attention toward
comorbidities, such as diabetes. The objectives of this review are to clarify the links between …

Importance One-third of patients with rheumatoid arthritis show inadequate response to
tumor necrosis factor α (TNF-α) inhibitors; little guidance on choosing the next treatment …

Introduction Shrinking lung syndrome (SLS) is a rare respiratory manifestation of systemic
lupus erythematosus (SLE), characterized by dyspnea, chest pain, elevated hemidiaphragm …

Objectives To analyze the clinical and immunological characteristics at enrollment in a large
prospective cohort of patients with primary Sjögren's syndrome (pSS) and to investigate the …

Objective To define parameters predictive of lymphoma development in patients with
primary Sjögren's syndrome (SS). Methods A multicenter case–control survey was …

As indicators of responsiveness to a tumour necrosis factor (TNF) α blocking agent
(infliximab) are lacking in rheumatoid arthritis, we have used gene profiling in peripheral …

Objective To identify a new autoantigen/autoantibody population in rheumatoid arthritis (RA)
sera. Methods Following a population‐based recruitment effort, 255 patients with very early …

Objective To retrospectively assess, with a sufficiently long followup (mean 11.6 years;
median 9 years), the long‐term outcome of chronic recurrent multifocal osteitis (CRMO), a …

Objectives No immunomodulatory drug has been approved for primary Sjögren's syndrome,
a systemic autoimmune disease affecting 0.1% of the population. To demonstrate the …